Your browser doesn't support javascript.
loading
A novel luminescence-based ß-arrestin recruitment assay for unmodified receptors.
Hauge Pedersen, Maria; Pham, Jennifer; Mancebo, Helena; Inoue, Asuka; Asher, Wesley B; Javitch, Jonathan A.
Afiliación
  • Hauge Pedersen M; Departments of Psychiatry & Molecular Pharmacology and Therapeutics, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York, USA; NNF Center for Basic Metabolic Resea
  • Pham J; Multispan Inc, Hayward, California, USA.
  • Mancebo H; Multispan Inc, Hayward, California, USA.
  • Inoue A; Department of Pharmacological Sciences, Tohoku University, Sendai, Japan.
  • Asher WB; Departments of Psychiatry & Molecular Pharmacology and Therapeutics, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York, USA.
  • Javitch JA; Departments of Psychiatry & Molecular Pharmacology and Therapeutics, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York, USA. Electronic address: javitch@nyspi.co
J Biol Chem ; 296: 100503, 2021.
Article en En | MEDLINE | ID: mdl-33684444
G protein-coupled receptors (GPCRs) signal through activation of G proteins and subsequent modulation of downstream effectors. More recently, signaling mediated by ß-arrestin has also been implicated in important physiological functions. This has led to great interest in the identification of biased ligands that favor either G protein or ß-arrestin-signaling pathways. However, nearly all screening techniques for measuring ß-arrestin recruitment have required C-terminal receptor modifications that can in principle alter protein interactions and thus signaling. Here, we have developed a novel luminescence-based assay to measure ß-arrestin recruitment to the membrane or early endosomes by unmodified receptors. Our strategy uses NanoLuc, an engineered luciferase from Oplophorus gracilirostris (deep-sea shrimp) that is smaller and brighter than other well-established luciferases. Recently, several publications have explored functional NanoLuc split sites for use in complementation assays. We have identified a unique split site within NanoLuc and fused the corresponding N-terminal fragment to either a plasma membrane or early endosome tether and the C-terminal fragment to ß-arrestins, which form the basis for the MeNArC and EeNArC assays, respectively. Upon receptor activation, ß-arrestin is recruited to the membrane and subsequently internalized in an agonist concentration-dependent manner. This recruitment promotes complementation of the two NanoLuc fragments, thereby reconstituting functional NanoLuc, allowing for quantification of ß-arrestin recruitment with a single luminescence signal. Our assay avoids potential artifacts related to C-terminal receptor modification and has promise as a new generic assay for measuring ß-arrestin recruitment to diverse GPCR types in heterologous or native cells.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Membrana Celular / Receptores Acoplados a Proteínas G / Beta-Arrestinas / Luciferasas Límite: Humans Idioma: En Revista: J Biol Chem Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Membrana Celular / Receptores Acoplados a Proteínas G / Beta-Arrestinas / Luciferasas Límite: Humans Idioma: En Revista: J Biol Chem Año: 2021 Tipo del documento: Article